Page 9 - Pharmaceutical
Aurobindo Pharma gets warning letter from USFDA for API facility
Aurobindo Pharma on Friday said it has received a warning letter from the US health regulator for its Hyderabad-based Unit I, an API manufacturing facility.
 "Aurobindo Pharma gets warning letter from USFDA for API facility")
Ipca Labs down 6% as stock turns ex-date for 1:1 split
The pharmaceutical company has fixed Tuesday, January 11, 2022, as the 'record date' for the members entitlement of sub-divided shares.
 "Ipca Labs down 6% as stock turns ex-date for 1:1 split")
What ails Indian pharmaceutical space? Here's what CCI says
Cardiac medicines accounted for the highest volumes in 2020. Despite the burden of diabetes rising, its share in volumes was low; however, its share in total value was higher
 "What ails Indian pharmaceutical space? Here's what CCI says")
Demerger to give a push to both pharma and financial services: Ajay Piramal
In a Q&A, the Chairman of Piramal Group talks about the prospects of both businesses, the rationale for the demerger and how supply side issues are impacting Indian companies
 "Demerger to give a push to both pharma and financial services: Ajay Piramal")
Drugs and Pharma sectors lead growth in India's exports from SEZs
Led by drugs and pharmaceuticals, India's exports from special economic Zones (SEZs) rose by 41.5 per cent on a year-on-year (YoY) basis to Rs 2.15 lakh crore in Q1FY22
 "Drugs and Pharma sectors lead growth in India's exports from SEZs")
Lupin, Glenmark shift focus to inhalation and nasal Covid-19 drugs
Lupin working on remdesivir powder inhaler; Glenmark to do trials on Nitric Oxide Nasal Spray
 "Lupin, Glenmark shift focus to inhalation and nasal Covid-19 drugs")
Alembic Pharma posts 45% dip in Q1 net at Rs 165 cr amid price erosion
Firm's consolidated revenues from operations also fell marginally to Rs 1,326 cr in Q1FY22, from Rs 1,341 crore a year ago
 "Alembic Pharma posts 45% dip in Q1 net at Rs 165 cr amid price erosion")
Premium valuations for specialty chemicals to sustain on multiple tailwinds
Near-term upsides however are limited given the spurt in stock prices
 "Premium valuations for specialty chemicals to sustain on multiple tailwinds")
Over 300 pharma, healthcare companies eligible for new Covid loans: Crisil
Hospitals to gain most with up to 3.5% dip on cost of funds; may add half a million beds, says rating agency
 "Over 300 pharma, healthcare companies eligible for new Covid loans: Crisil")
A dynastic dive into opioids
Book review of Empire of Pain: The Secret History of the Sackler Dynasty
 "A dynastic dive into opioids")
Indian pharma exports grow at 18% to $24.44 billion in FY 21 from $20.58 bn
Pharma exports from India witnessed over 18 per cent growth to USD 24.44 billion during the last financial year against USD 20.58 billion in FY20
PM Narendra Modi to talk PLI scheme road map with India Inc this week
Top executives from telecom, electronics, food processing, pharmaceuticals, steel, and textiles will interact with the PM on Friday via video conferencing
 "PM Narendra Modi to talk PLI scheme road map with India Inc this week")
Dr Reddy's launches stomach, esophagus problems treatment drug in US
The product is a therapeutic equivalent generic version of Prevacid SoluTab delayed release orally disintegrating tablets approved by the US Food and Drug Administration (USFDA)
 "Dr Reddy's launches stomach, esophagus problems treatment drug in US")
Glenmark Pharma gets USFDA approval for nervous system stimulant drug
Glenmark Pharmaceuticals Ltd has been granted final approval by the United States Food and Drug Administration (USFDA) for Amphetamine Sulfate tablets USP
 "Glenmark Pharma gets USFDA approval for nervous system stimulant drug")
The next online tonic: E-majors, corporate giants eye e-pharmacy business
Amazon, Reliance recently announced their foray into e-pharma sector
 "The next online tonic: E-majors, corporate giants eye e-pharmacy business")
Activists urge 'Big Pharma' to be transparent on Covid-19 vaccine costs
Medecins Sans Frontieres (Doctors Without Borders) demanded that companies provide details around price, supply and distribution of any vaccine proven safe and effective
 "Activists urge 'Big Pharma' to be transparent on Covid-19 vaccine costs")
Short-cut to save lives: How pharma is changing to develop Covid-19 vaccine
Making medicines is expensive, and it can take a very long time to get from the discovery of a drug to actually treating patients
 "Short-cut to save lives: How pharma is changing to develop Covid-19 vaccine")
Sun Pharma bullish on specialty biz, looks to expand to new geographies
Sun Pharmaceutical Industries Managing Director Dilip Shanghvi said the company''s strategy of developing the specialty business as an additional growth engine has started delivering results
 "Sun Pharma bullish on specialty biz, looks to expand to new geographies")
Launch of inhalation product improves Lupin's revenue visibility
More US launches and uptick in the Indian market are key near-term triggers
Lupin gets USFDA approval for asthmatic symptoms prevention drug
Drug major Lupin on Tuesday said it has received approval from the US health regulator for its Albuterol Sulfate Inhalation Aerosol, used for treatment of acute episodes of bronchospasm or prevention of asthmatic symptoms. The approved product is a generic version of ProAir HFA of Teva Branded Pharmaceutical Products R&D, Inc. In a regulatory filing, Lupin said it has received approval from the United States Food and Drug Administration (USFDA) for its Albuterol Sulfate Inhalation Aerosol, 90 mcg (base)/actuation. Vinita Gupta, CEO, Lupin said: "The approval is timely as Albuterol MDI is a key rescue inhalation product for asthma patients who are at an increased risk of COVID-19-related complications. We look forward to launching the product this quarter and expect a steady ramp-up through the fiscal year. Quoting IQVIA moving annual total June 2020 data, Lupin said the total Albuterol Sulfate Inhalation Aerosol market had US sales of approximately USD 2.9 billion, of which the ...
